More SEC Filings
View Older Stories View Newer Stories-
Form 424B2 JPMORGAN CHASE & CO
-
Form D/A Public Equity Tail Hedge
-
Form 8-K United Homes Group, Inc. For: Jun 12
-
Form 6-K DHT Holdings, Inc. For: Jun 12
-
Form C-U Westbound & Down Brewing
-
Form D/A Absolute Return Portfoli
-
Form D/A Absolute Return Parallel
-
Form 424B2 JPMORGAN CHASE & CO
-
Form D/A Emerging Markets Portfol
-
Form D/A Emerging Markets Portfol
-
Form 8-K Sensei Biotherapeutics, For: Jun 12
-
Form 8-K Akebia Therapeutics, For: Jun 10
-
Form 144 Li Auto Inc. Filed by: Ma Donghui
-
Form 4 CONDUIT PHARMACEUTICALS For: Jun 03 Filed by: Corvus Capital Ltd.
-
Form 424B5 WESTWATER RESOURCES,
-
Form 8-K ARVINAS, INC. For: Jun 13
-
Form DEFA14A Katapult Holdings, Inc.
-
Form 6-K NOVO NORDISK A S For: Jun 12
-
Form MA/A SIEBERT WILLIAMS SHANK
-
Form 8-K CITIZENS FINANCIAL GROUP For: Jun 13
-
Form 11-K DOW INC. For: Dec 31
-
Form 6-K MoneyHero Ltd For: Jun 13
-
Form TA-1 Upside TA, LLC
-
Form 8-K Tonix Pharmaceuticals For: Jun 12
-
Form TA-1 BLACK UNICORN EQUITY
-
Form FWP XTI Aerospace, Inc. Filed by: XTI Aerospace, Inc.
-
Form 8-K Katapult Holdings, Inc. For: Jun 12
-
Form 8-K Agrify Corp For: Jun 11
-
Form 8-K AMERICAN PUBLIC EDUCATIO For: Jun 13
-
Form 6-K ZKH Group Ltd For: Jun 13
-
Form 6-K GH Research PLC For: Jun 13
-
Form 6-K Quantum Biopharma Ltd. For: Jun 13
-
Form 6-K PRUDENTIAL PLC For: Jun 13
-
Form 8-K WESTWATER RESOURCES, For: Jun 13
-
Form 8-K PROS Holdings, Inc. For: Jun 12
-
Form 6-K Melco Resorts & Entertai For: Jun 13
-
Form 10-Q Leopard Energy, Inc. For: Apr 30
-
Form 15-12G Equity Commonwealth
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 6-K PERUSAHAAN PERSEROAN For: Jun 13
-
Form 6-K GSK plc For: Jun 13
-
Form MA-I SIEBERT WILLIAMS SHANK
-
Form MA-I/A SIEBERT WILLIAMS SHANK
-
Form MA-I/A SIEBERT WILLIAMS SHANK
-
Form 8-K Inception Growth Acquisi For: Jun 10
-
Form F-3ASR BW LPG Ltd
-
Form S-8 Sila Realty Trust, Inc.
-
Form 8-K/A CHIMERA INVESTMENT CORP For: Jun 11
-
Form 4 POWER SOLUTIONS INTERNAT For: Jun 11 Filed by: Xykis Constantine
-
Form S-3MEF Enliven Therapeutics,

